Advertisement
Screener

VICARIOUS SURGICAL INC. (RBOT) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested

1.0 / 5 stars · 6/30 Roast Me

VICARIOUS SURGICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested

VICARIOUS SURGICAL INC. (RBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $269.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2025-11-12

  • VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2025-09-30 was $49.00K, a 77.83% decline year-over-year.
  • VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2025-06-30 was $80.00K, a 44.44% decline year-over-year.
  • VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2025-03-31 was $140.00K, a 18.13% decline year-over-year.
  • VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2024-09-30 was $221.00K, a 56.32% decline year-over-year.
  • VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2022 was $2.03M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month
2025-09-30$49.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$129.00K
derived: sum of 2 quarters · filed 2025-11-12
$269.00K
10-Q · filed 2025-11-12
2025-06-30$80.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$220.00K
10-Q · filed 2025-08-12
2025-03-31$140.00K
10-Q · filed 2025-05-12
2024-09-30$221.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$365.00K
derived: sum of 2 quarters · filed 2024-11-12
$536.00K
10-Q · filed 2024-11-12
2024-06-30$144.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$315.00K
10-Q · filed 2024-08-13
2024-03-31$171.00K
10-Q · filed 2024-04-29
2023-09-30$506.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$1.88M
10-Q · filed 2023-11-13
2023-06-30$1.37M
10-Q · filed 2023-07-28
2022-12-31$2.03M
10-K · filed 2024-03-04
2022-06-30$1.37M
10-Q · filed 2023-07-28